A Phase II Study of Flavopiridol in Patients With Previously Untreated Advanced Soft Tissue Sarcoma

Purpose. Flavopiridol is a potent cyclin-dependent kinase (CDK) inhibitor that has preclinical activity in many tumours. This synthetic flavonoid was tested in a phase II nonrandomized, nonblinded multicentre clinical trial to determine its activity and toxicity in patients with previously untreated...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Morris, Don G., Bramwell, Vivien H. C., Turcotte, Robert, Figueredo, Alvaro T., Blackstein, Martin E., Verma, Shail, Matthews, Sarah, Eisenhauer, Elizabeth A.
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2006
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1698142/
https://ncbi.nlm.nih.gov/pubmed/17251659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/SRCM/2006/64374
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires